Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and the registrant customarily and actually treats as private and confidential. RESEARCH COLLABORATION AND...Collaboration and License Agreement • March 17th, 2022 • Century Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Research Collaboration and License Agreement (this “Agreement”), is made and entered into as of January 7, 2022 (the “Effective Date”), by and between Bristol-Myers Squibb Company, a Delaware corporation having a place of business at 430 E. 29th Street, 14th Floor, New York, New York, 10016 (“BMS”), and Century Therapeutics, Inc., a Delaware corporation having a place of business at 3675 Market Street, Philadelphia, PA 19104 (“Century”). BMS and Century are referred to individually as a “Party” and collectively as the “Parties.”
